Trial status
DISEASE, RECRUITMENT
Protocol of submitted version, number and date: number 1.2; date September 2022.Recruitment: date of first enrolment: November 28, 2022, and recruitment will be completed by November, 2024.Revision chronology:a-EndoCir April, 2019, original: version 1, first draft of the study protocol.b-EndoCir September, 2022, amendment n° 1: version 1.2 - definitive.Minor changes: changes in statistical analysis methods and cost analysis.New variables added: faecal calprotectin (optional) to evaluate the clinical activity of the disease.Updated list of the most common pharmacological treatments in CD and Patient Reported Outcomes Measures (PROMs) added: IBD-Control questionnaire.